Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

D. Branch Moody, M.D.

Concepts

This page shows the publications D. Moody has written about Tuberculosis.
Connection Strength

1.663
  1. Peripheral Blood Mucosal-Associated Invariant T Cells in Tuberculosis Patients and Healthy Mycobacterium tuberculosis-Exposed Controls. J Infect Dis. 2020 08 17; 222(6):995-1007.
    View in: PubMed
    Score: 0.368
  2. In vivo biosynthesis of terpene nucleosides provides unique chemical markers of Mycobacterium tuberculosis infection. Chem Biol. 2015 Apr 23; 22(4):516-526.
    View in: PubMed
    Score: 0.255
  3. CD1 and mycobacterial lipids activate human T cells. Immunol Rev. 2015 Mar; 264(1):138-53.
    View in: PubMed
    Score: 0.252
  4. Synthetic mycobacterial diacyl trehaloses reveal differential recognition by human T cell receptors and the C-type lectin Mincle. Sci Rep. 2021 01 21; 11(1):2010.
    View in: PubMed
    Score: 0.095
  5. CD1b Tetramers Broadly Detect T Cells That Correlate With Mycobacterial Exposure but Not Tuberculosis Disease State. Front Immunol. 2020; 11:199.
    View in: PubMed
    Score: 0.089
  6. Early progression to active tuberculosis is a highly heritable trait driven by 3q23 in Peruvians. Nat Commun. 2019 08 21; 10(1):3765.
    View in: PubMed
    Score: 0.086
  7. CD1b Tetramers Identify T Cells that Recognize Natural and Synthetic Diacylated Sulfoglycolipids from Mycobacterium tuberculosis. Cell Chem Biol. 2018 04 19; 25(4):392-402.e14.
    View in: PubMed
    Score: 0.077
  8. Mycobacterial Metabolic Syndrome: LprG and Rv1410 Regulate Triacylglyceride Levels, Growth Rate and Virulence in Mycobacterium tuberculosis. PLoS Pathog. 2016 Jan; 12(1):e1005351.
    View in: PubMed
    Score: 0.067
  9. HIV Disrupts Human T Cells That Target Mycobacterial Glycolipids. J Infect Dis. 2016 Feb 15; 213(4):628-33.
    View in: PubMed
    Score: 0.065
  10. Biomarkers for Tuberculosis Based on Secreted, Species-Specific, Bacterial Small Molecules. J Infect Dis. 2015 Dec 01; 212(11):1827-34.
    View in: PubMed
    Score: 0.064
  11. Cutting Edge: CD1a tetramers and dextramers identify human lipopeptide-specific T cells ex vivo. J Immunol. 2013 Nov 01; 191(9):4499-503.
    View in: PubMed
    Score: 0.057
  12. The polyketide Pks1 contributes to biofilm formation in Mycobacterium tuberculosis. J Bacteriol. 2012 Feb; 194(3):715-21.
    View in: PubMed
    Score: 0.050
  13. T-cell responses to CD1-presented lipid antigens in humans with Mycobacterium tuberculosis infection. Infect Immun. 2003 Jun; 71(6):3076-87.
    View in: PubMed
    Score: 0.028
  14. Heterologous Production of 1-Tuberculosinyladenosine in Mycobacterium kansasii Models Pathoevolution towards the Transcellular Lifestyle of Mycobacterium tuberculosis. mBio. 2020 10 20; 11(5).
    View in: PubMed
    Score: 0.023
  15. CD1c-mediated T-cell recognition of isoprenoid glycolipids in Mycobacterium tuberculosis infection. Nature. 2000 Apr 20; 404(6780):884-8.
    View in: PubMed
    Score: 0.023
  16. Protein kinases PknA and PknB independently and coordinately regulate essential Mycobacterium tuberculosis physiologies and antimicrobial susceptibility. PLoS Pathog. 2020 04; 16(4):e1008452.
    View in: PubMed
    Score: 0.022
  17. Targeted delivery of mycobacterial antigens to human dendritic cells via Siglec-7 induces robust T cell activation. J Immunol. 2014 Aug 15; 193(4):1560-6.
    View in: PubMed
    Score: 0.015
  18. The Mycobacterium tuberculosis regulatory network and hypoxia. Nature. 2013 Jul 11; 499(7457):178-83.
    View in: PubMed
    Score: 0.014
  19. Asymmetric synthesis and structure elucidation of a glycerophospholipid from Mycobacterium tuberculosis. J Lipid Res. 2010 May; 51(5):1017-22.
    View in: PubMed
    Score: 0.011
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.